{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T10:30:37Z","timestamp":1756463437238,"version":"3.40.5"},"reference-count":17,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.clml.2024.06.003","type":"journal-article","created":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T17:35:11Z","timestamp":1718732111000},"page":"e385-e391.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Impact of Facility Type on Survival in Chronic Myelomonocytic Leukemia: A Propensity Score Matched, National Cancer Database Analysis"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5188-2099","authenticated-orcid":false,"given":"Serena","family":"Tharakan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0144-1185","authenticated-orcid":false,"given":"Jonathan","family":"Feld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-8791-2285","authenticated-orcid":false,"given":"Grace","family":"Van Hyfte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8400-0483","authenticated-orcid":false,"given":"John","family":"Mascarenhas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas","family":"Tremblay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.clml.2024.06.003_bib0001","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1182\/blood-2016-05-714030","article-title":"Integrating clinical features and genetic lesions in the risk assessment of patients with chronic myelomonocytic leukemia","volume":"128","author":"Elena","year":"2016","journal-title":"Blood"},{"issue":"15","key":"10.1016\/j.clml.2024.06.003_bib0002","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1182\/bloodadvances.2018019224","article-title":"Validation of the 2017 revision of the WHO chronic myelomonocytic leukemia categories","volume":"2","author":"Loghavi","year":"2018","journal-title":"Blood Adv"},{"issue":"1","key":"10.1016\/j.clml.2024.06.003_bib0003","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1182\/blood-2008-01-134858","article-title":"Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001-2004, using data from the NAACCR and SEER programs","volume":"112","author":"Rollison","year":"2008","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.clml.2024.06.003_bib0004","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/ajh.23962","article-title":"Blast transformation in chronic myelomonocytic leukemia: Risk factors, genetic features, survival, and treatment outcome","volume":"90","author":"Patnaik","year":"2015","journal-title":"Am J Hematol"},{"issue":"7","key":"10.1016\/j.clml.2024.06.003_bib0005","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.3324\/haematol.2021.279500","article-title":"How I diagnose and treat chronic myelomonocytic leukemia","volume":"107","author":"Patnaik","year":"2022","journal-title":"Haematologica"},{"key":"10.1016\/j.clml.2024.06.003_bib0006","doi-asserted-by":"crossref","DOI":"10.21037\/ace-22-12","article-title":"Facility type and volume impact outcomes in acute myeloid leukemia\u2014a National Cancer Database Study","volume":"7","author":"Taylor","year":"2023","journal-title":"Annals of Cancer Epidemiology"},{"issue":"8","key":"10.1016\/j.clml.2024.06.003_bib0007","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1002\/ajh.24767","article-title":"Early mortality and overall survival of acute myeloid leukemia based on facility type","volume":"92","author":"Bhatt","year":"2017","journal-title":"Am J Hematol"},{"issue":"12","key":"10.1016\/j.clml.2024.06.003_bib0008","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1200\/OP.23.00373","article-title":"Impact of Specialized Treatment Setting on Survival in Adolescent and Young Adult ALL","volume":"19","author":"Muffly","year":"2023","journal-title":"JCO Oncol Pract"},{"issue":"1","key":"10.1016\/j.clml.2024.06.003_bib0009","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1080\/10428194.2021.1975187","article-title":"Acute lymphoblastic leukemia (ALL) in adults: disparities in treatment intervention based on access to treatment facility","volume":"63","author":"Khullar","year":"2022","journal-title":"Leuk Lymphoma"},{"issue":"1","key":"10.1016\/j.clml.2024.06.003_bib0010","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1182\/bloodadvances.2023011862","article-title":"Socioeconomic determinants of the biology and outcomes of acute lymphoblastic leukemia in adults","volume":"8","author":"Johnston","year":"2024","journal-title":"Blood Adv"},{"issue":"23","key":"10.1016\/j.clml.2024.06.003_bib0011","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1182\/blood.V126.23.533.533","article-title":"Overall Survival (OS) of Acute Myeloid Leukemia (AML) Treated at Academic Center (AC) Versus Non-Academic Center (NAC)","volume":"126","author":"Giri","year":"2015","journal-title":"Blood,"},{"issue":"3","key":"10.1016\/j.clml.2024.06.003_bib0012","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/jnci\/djy221","article-title":"Systematic Review and Meta-Analysis of the Magnitude of Structural, Clinical, and Physician and Patient Barriers to Cancer Clinical Trial Participation","volume":"111","author":"Unger","year":"2019","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.clml.2024.06.003_bib0013","unstructured":"Bureau, U.S.C., 2022."},{"issue":"14","key":"10.1016\/j.clml.2024.06.003_bib0014","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1182\/blood.2021012830","article-title":"Structural racism is a mediator of disparities in acute myeloid leukemia outcomes","volume":"139","author":"Abraham","year":"2022","journal-title":"Blood"},{"journal-title":"Leuk Res","year":"2015","author":"Calvo","key":"10.1016\/j.clml.2024.06.003_bib0015"},{"issue":"1","key":"10.1016\/j.clml.2024.06.003_bib0016","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1182\/hematology.2020000096","article-title":"Optimizing management of acute leukemia in community centers and when to refer","volume":"2020","author":"Jillella","year":"2020","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"1","key":"10.1016\/j.clml.2024.06.003_bib0017","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1182\/hematology.2020000097","article-title":"Practice patterns and outcomes for adults with acute myeloid leukemia receiving care in community vs academic settings","volume":"2020","author":"Halpern","year":"2020","journal-title":"Hematology Am Soc Hematol Educ Program"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265024002374?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265024002374?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T15:10:52Z","timestamp":1729696252000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265024002374"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":17,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S2152265024002374"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2024.06.003","relation":{},"ISSN":["2152-2650"],"issn-type":[{"type":"print","value":"2152-2650"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of Facility Type on Survival in Chronic Myelomonocytic Leukemia: A Propensity Score Matched, National Cancer Database Analysis","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2024.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}